These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35273524)

  • 21. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
    Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
    Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased dorsal attention network homogeneity as a potential neuroimaging biomarker for major depressive disorder.
    Gao Y; Guo X; Zhong Y; Liu X; Tian S; Deng J; Lin X; Bao Y; Lu L; Wang G
    J Affect Disord; 2023 Jul; 332():136-142. PubMed ID: 36990286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline cognitive functioning can predict the trajectory of acute treatment in first-episode major depressive disorder.
    Liu S; Tong Y; Wang X; Yu X; Xu Y
    Eur Arch Psychiatry Clin Neurosci; 2023 Aug; 273(5):1129-1137. PubMed ID: 35969275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
    Saricicek Aydogan A; Oztekin E; Esen ME; Dusmez S; Gelal F; Besiroğlu L; Zorlu N
    Acta Psychiatr Scand; 2019 Sep; 140(3):217-226. PubMed ID: 31250445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls.
    Zhu ZH; Song XY; Man LJ; Chen P; Tang Z; Li RH; Ji CF; Dai NB; Liu F; Wang J; Zhang J; Jia QF; Hui L
    Front Psychiatry; 2022; 13():858675. PubMed ID: 35492731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Response Prediction for Major Depressive Disorder Patients
    Li H; Song S; Wang D; Zhang D; Tan Z; Lian Z; Wang Y; Zhou X; Pan C; Wu Y
    Front Comput Neurosci; 2022; 16():837093. PubMed ID: 35720774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
    Lin CH; Park C; McIntyre RS
    J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
    Lin HS; Lin CH
    J Affect Disord; 2019 Feb; 245():91-97. PubMed ID: 30368075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimaging markers of adolescent depression in the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study.
    Meruelo AD; Brumback T; Nagel BJ; Baker FC; Brown SA; Tapert SF
    J Affect Disord; 2021 May; 287():380-386. PubMed ID: 33836366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials.
    Gomeni R; Merlo-Pich E
    Br J Clin Pharmacol; 2007 May; 63(5):595-613. PubMed ID: 17488364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical thickness differences between bipolar depression and major depressive disorder.
    Lan MJ; Chhetry BT; Oquendo MA; Sublette ME; Sullivan G; Mann JJ; Parsey RV
    Bipolar Disord; 2014 Jun; 16(4):378-88. PubMed ID: 24428430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep disturbance-related neuroimaging features as potential biomarkers for the diagnosis of major depressive disorder: A multicenter study based on machine learning.
    Shi Y; Zhang L; He C; Yin Y; Song R; Chen S; Fan D; Zhou D; Yuan Y; Xie C; Zhang Z
    J Affect Disord; 2021 Dec; 295():148-155. PubMed ID: 34461370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study.
    Yuan H; Zhu X; Luo Q; Halim A; Halim M; Yao H; Cai Y; Shi S
    Neuropsychiatr Dis Treat; 2019; 15():957-966. PubMed ID: 31354272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
    Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
    Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiolipin Antibody: A Potential Biomarker for Depression.
    Costa R; Fatourou E; Hoppensteadt D; Fareed J; Halaris A
    J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36573728
    [No Abstract]   [Full Text] [Related]  

  • 38. Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report.
    Hough CM; Bersani FS; Mellon SH; Epel ES; Reus VI; Lindqvist D; Lin J; Mahan L; Rosser R; Burke H; Coetzee J; Nelson JC; Blackburn EH; Wolkowitz OM
    Mol Neuropsychiatry; 2016 Jul; 2(2):88-96. PubMed ID: 27429957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study.
    He S; Zeng D; Xu F; Zhang J; Zhao N; Wang Q; Shi J; Lin Z; Yu W; Li H
    Front Psychiatry; 2019; 10():378. PubMed ID: 31244689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder.
    Gao W; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Psychol Res Behav Manag; 2022; 15():2971-2978. PubMed ID: 36310625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.